Haven't been on here for a couple months since selling out. Briefly skimmed through the Q2 numbers. Awful. No progress has been made on pretty much anything. BIEL got denied for a second time with FDA - there's no shortcut way of getting product on shelves in the U.S. any time soon. Will likely have to finish up those 10 clinical trials before re-submitting data. Hopefully they're being conducted in a proper matter...
More distributors, flat sales. It's clear that the company will need to raise more cash soon. Can't support it's operations without it. This, combined with pending debt conversion doesn't make me want to touch this thing with a ten foot pole.
Glad I got out when I did. O/S will begin to approach 4 billion shares...a R/S will definitely be needed.
News 
Market Data 
Discover 
AI
